These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35087410)

  • 1. Investigating the Efficacy and Safety of Thalidomide for Treating Patients With
    Lu Y; Wei Z; Yang G; Lai Y; Liu R
    Front Pharmacol; 2021; 12():814302. PubMed ID: 35087410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of thalidomide for various genotypes of beta thalassemia.
    Yang WJ; Kang QP; Zhou Q; Lin T; Gong XM; Huang CJ; Dou M; Lin Y
    BMC Med Genomics; 2024 Jul; 17(1):191. PubMed ID: 39026312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide for Patients with β-Thalassemia: A Multicenter Experience.
    Yang K; Wu Y; Zhou Y; Long B; Lu Q; Zhou T; Wang L; Geng Z; Yin X
    Mediterr J Hematol Infect Dis; 2020; 12(1):e2020021. PubMed ID: 32395210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Thalidomide in Patients With Transfusion-Dependent Thalassemia.
    Chandra J; Parakh N; Sidharth ; Singh N; Sharma S; Goel M; Pemde H
    Indian Pediatr; 2021 Jul; 58(7):611-616. PubMed ID: 34315832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent
    Che J; Luo T; Huang L; Lu Q; Yan D; Meng Y; Xie J; Chen W; Chen J; Long L
    Front Pharmacol; 2022; 13():810668. PubMed ID: 35250561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.
    Ali Z; Ismail M; Rehman IU; Rani GF; Ali M; Khan MTM
    Sci Rep; 2023 Aug; 13(1):13592. PubMed ID: 37604857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia.
    Ren Q; Zhou YL; Wang L; Chen YS; Ma YN; Li PP; Yin XL
    Ann Hematol; 2018 Oct; 97(10):1933-1939. PubMed ID: 29931453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life.
    Bhattacharjee S; Ghosh S; Shaw J; Bhattacharjee S; Bhattacharyya M
    Hemoglobin; 2024 May; 48(3):161-168. PubMed ID: 39092801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study.
    Li X; Hu S; Liu Y; Huang J; Hong W; Xu L; Xu H; Fang J
    Front Pharmacol; 2021; 12():722502. PubMed ID: 34456732
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial.
    Chen JM; Zhu WJ; Liu J; Wang GZ; Chen XQ; Tan Y; Xu WW; Qu LW; Li JY; Yang HJ; Huang L; Cai N; Wang WD; Huang K; Xu JQ; Li GH; He S; Luo TY; Huang Y; Liu SH; Wu WQ; Lu QY; Zhou MG; Chen SY; Li RL; Hu ML; Huang Y; Wei JH; Li JM; Chen SJ; Zhou GB
    Signal Transduct Target Ther; 2021 Nov; 6(1):405. PubMed ID: 34795208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients.
    Bhurani D; Kapoor J; Yadav N; Khushoo V; Agrawal N; Ahmed R; Arora JS; Mehta P
    Ann Hematol; 2021 Jun; 100(6):1417-1427. PubMed ID: 33811502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India.
    Jain M; Chakrabarti P; Dolai TK; Ghosh P; Mandal PK; Baul SN; De R
    Blood Cells Mol Dis; 2021 May; 88():102544. PubMed ID: 33610115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising Response to Thalidomide in Symptomatic β-Thalassemia.
    Yassin AK
    Indian J Hematol Blood Transfus; 2020 Apr; 36(2):337-341. PubMed ID: 32425386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictors of Hematologic Responses in Patients with Non-Transfusion-Dependent β-Thalassemia Receiving Thalidomide Therapy].
    Yang K; Yin XL; Liu XD; Hua F; Peng W; Li L; Chen K; Zhang J; Luo S; Xiao J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1519-1526. PubMed ID: 36208259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Thalidomide and Hydroxyurea Combination in Beta Thalassemia Patients.
    Garg A; Patel K; Shah K; Trivedi D; Raj A; Yadav R; Shah S
    Indian J Hematol Blood Transfus; 2023 Jan; 39(1):85-89. PubMed ID: 36699430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD004450. PubMed ID: 23963793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Aγ-globin G->A gene polymorphism associated with β
    Breveglieri G; Bianchi N; Cosenza LC; Gamberini MR; Chiavilli F; Zuccato C; Montagner G; Borgatti M; Lampronti I; Finotti A; Gambari R
    BMC Med Genet; 2017 Aug; 18(1):93. PubMed ID: 28851297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trials.
    Gao M; Kong Y; Wang H; Xie B; Yang G; Gao L; Zhang Y; Zhan F; Dai B; Tao Y; Shi J
    Tumour Biol; 2016 Aug; 37(8):11081-98. PubMed ID: 26906553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Hydroxyurea in Transfusion-Dependent Major β-Thalassemia Patients: A Meta-Analysis.
    Hatamleh MI; Chenna VSH; Contractor H; Krishna Mohan GV; Tirumandyam G; Dammas N; Khan MW; Hirani S
    Cureus; 2023 Apr; 15(4):e38135. PubMed ID: 37252463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Thalidomide on Erythropoiesis and Iron Homeostasis in Transfusion-Dependent β-Thalassemia.
    Yang K; Liu X; Peng W; Hua F; Li L; Chen K; Zhang J; Luo S; Li W; Ding Y; Chen J; Xiao J
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024001. PubMed ID: 38223482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.